Sulfotransferase 1A1 Arg213His polymorphism and prostate cancer risk

Experimental and Therapeutic Medicine

Volumn 2, Issue 6, 2011, Pages 1159-1162

  Arslan, Serdal ^a   Silig, Yavuz ^a   Pinarbasi, Hatice ^a  

^a CUMHURIYET UNIVERSITY   (Turkey)

Author keywords

Genetic polymorphism; Prostate cancer; Sulfotransferase 1A1; Turkish population

Indexed keywords

SULFOTRANSFERASE 1A1;

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER RISK; CONTROLLED STUDY; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PROSTATE CANCER; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SMOKING;

EID: 80052745146     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2011.334     Document Type: Article

References (26)

1. Falany CN: Enzymology of human cytosolic sulfotransferases. FASEB J 11: 206-216, 1997.
2. Glatt H, Engelke CE, Pabel U, Teubner W, Jones AL, Coughtrie MW, Andrae U, Falany CN and Meinl W: Sulfo-transferases: genetics and role in toxicology. Toxicol Lett 112: 341-348, 2000.
3. Richard K, Hume R, Kaptein E, Stanley EL, Visser TJ and Coughtrie MW: Sulfation of thyroid hormone and dopamine during human development: ontogeny of phenol sulfotransferases and arylsulfatase in liver, lung, and brain. J Clin Endocrinol Metab 86: 2734-2742, 2001.
4. Blanchard RL, Freimuth RR, Buck J, Weinshilboum RM and Coughtrie MW: A proposed nomenclature system for the cytosolic sulfotransferase (SULT) superfamily. Pharmacogenetics 14: 199-211, 2004.
5. Raftogianis RB, Wood TC, Otterness DM, Van Loon JA and Weinshilboum RM: Phenol sulfotransferase pharmacogenetics in human: association of common SULT1A1 alleles with TS PST phenotype. Biochem Biophys Res Commun 239: 298-304, 1997.
6. Nowell S, Ambrosone CB, Ozawa S, MacLeod SL, Mrackova G, Williams S, Plaxco J, Kadlubar FF and Lang NP: Relationship of phenol sulfotransferase activity (SULT1A1) genotype to sulfotransferase phenotype in platelet cytosol. Pharmacogenetics 10: 789-797, 2000.
7. National Cancer Institute: Annual Report to the Nation Finds Declines in Cancer Incidence and Death Rates; Special Feature Reveals Wide Variations in Lung Cancer Trends across States. www.cancer.gov/newscenter/pressreleases/2008/reportnation2008release.
8. Dearnaley DP: Cancer of the prostate. BMJ 308: 780-784, 1994. Erratum in: BMJ 308: 975, 1994.
9. Bamber DE, Fryer AA, Strange RC, Elder JB, Deakin M, Rajagopal R, Fawole A, Gilissen RA, Campbell FC and Coughtrie MW: Phenol sulfotransferase SUL1A1*1 genotype is associated with reduced risk of colorectal cancer. Pharmacogenetics 11: 679-685, 2001.
10. Boccia S, Persiani R, La Torre G, Rausei S, Arzani D, Gianfagna F, Romano-Spica V, D'Ugo D and Ricciardi G: Sulfotransferase 1A1 polymorphism and gastric cancer risk: a pilot case-control study. Cancer Lett 229: 235-243, 2005.
11. Nowell S, Ratnasinghe DL, Ambrosone CB, Williams S, Teague-Ross T, Trimble L, Runnels G, Carrol A, Green B, Stone A, Johnson D, Greene G, Kadlubar FF and Lang NP: Association of SULT1A1 phenotype and genotype with prostate cancer risk in African-Americans and Caucasians. Cancer Epidemiol Biomarkers Prev 13: 270-276, 2004.
12. Peng CT, Chen JC, Yeh KT, Wang YF, Hou MF, Lee TP, Shih MC, Chang JY and Chang JG: The relationship among the polymorphisms of SULT1A1, 1A2 and different types of cancers in Taiwanese. Int J Mol Med 11: 85-89, 2003.
13. Seth P, Lunetta KL, Bell DW, Gray H, Nasser SM, Rhei E, Kaelin CM, Iglehart DJ, Marks JR, Garber JE, Haber DA and Polyak K: Phenol sulfotransferases: hormonal regulation, polymorphism, and age of onset of breast cancer. Cancer Res 60: 6859-6863, 2000.
14. Silig Y, Pinarbasi{dotless} H, Güneş S, Ayan S, Bagci H and Çetinkaya Ö: Polymorphisms of CYP1A1, GSTM1, GSTT1, and prostate cancer risk in Turkish population. Cancer Invest 24: 41-45, 2006.
15. Steiner M, Bastian M, Schulz WA, Pulte T, Franke KH, Röhring A, Wolff JM, Seiter H and Schuff-Werner P: Phenol sulphotransferase SULT1A1 polymorphism in prostate cancer: lack of association. Arch Toxicol 74: 222-225, 2000.
16. Zheng W, Xie D, Cerhan JR, Sellers TA, Wen W and Folsom AR: Sulfotransferase 1A1 polymorphism, endogenous estrogen exposure, well-done meat-intake, and breast cancer risk. Cancer Epidemiol Biomarkers Prev 10: 89-94, 2001.
17. Sambrook J, Fritsch E and Maniatis T (eds): Molecular Cloning A Laboratory Manual. 2nd edition, Cold Spring Harbor Laboratory Press, Plainview, 1989.
18. Wormhoudt LW, Commandeur JN and Vermeulen NP: Genetic polymorphisms of human N-acetyltransferase, cytochrome P450, glutathione-S-transferase, and epoxide hydrolase enzymes: relevance to xenobiotic metabolism and toxicity. Crit Rev Toxicol 29: 59-124, 1999.
19. Coughtrie MW, Gilissen RA, Shek B, Strange RC, Fryer AA, Jones PW and Bamber DE: Phenol sulphotransferase SULT1A1 polymorphism: molecular diagnosis and allele frequencies in Caucasian and African populations. Biochem J 337: 45-49, 1999.
20. 213 His polymorphism and lung cancer susceptibility in a Turkish population. Cell Biochem Funct 27: 1-5, 2009.
21. Kim KA, Lee SY, Park PW, Ha JM and Park JY: Genetic polymorphisms and linkage disequilibrium of sulfotransferase SULT1A1 and SULT1A2 in a Korean population: comparison of other ethnic groups. Eur J Clin Pharmacol 61: 743-747, 2005.
22. Bardakci F, Arslan S, Bardakci S, Binatli AO and Budak M: Sulfotransferase 1A1 (SULT1A1) polymorphism and susceptibility to primary brain tumors. J Cancer Res Clin Oncol 134: 109-114, 2008.
23. Banoglu E: Current status of the cytosolic sulfotransferases in the metabolic activation of promutagens and procarcinogens. Curr Drug Metab 1: 1-30, 2000.
24. Shirai T, Tamano S, Sano M, Masui T, Hasegawa R and Ito N: Carcinogenicity of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in rats: dose-response studies. Princess Takamatsu Symp 23: 232-239, 1995.
25. Chou HC, Lang NP and Kadlubar FF: Metabolic activation of the N-hydroxy derivative of the carcinogen 4-aminobiphenyl by human tissue sulfotransferases. Carcinogenesis 16: 413-417, 1995.
26. Ozawa S, Chou HC, Kadlubar FF, Nagata K, Yamazoe Y and Kato R: Activation of 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine by cDNA-expressed human and rat arylsulfotransferases. Jpn J Cancer Res 85: 1220-1228, 1994.